IFNG and hepatocellular carcinoma: IFN-γ is mainly released by T cells that are recognized and activated by antigens [32], which can induce the expression of B7-H1 gene in lung cancer cells, bile duct cancer cells, head and neck cancers, and HCC through JAK/STAT1 pathway [32–35].